Plain-English translation of NCT02302742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a research registry that collects medical information and genetic data from people newly diagnosed with triple negative breast cancer, as well as people who carry hereditary breast and ovarian cancer gene mutations (like BRCA). The goal is to understand how genetic changes influence cancer development and outcomes, which could help doctors better predict and treat these cancers in the future.
Triple negative breast cancer is an aggressive form of breast cancer that responds differently to treatment than other types. Researchers don't yet fully understand how genetic mutations influence who develops this cancer and how their disease progresses. By collecting information from many patients over time, this study aims to uncover those connections.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your medical records, cancer history, and genetic test results with the research team. There is no medication to take or medical procedures to undergo — this is purely an information-gathering study. Depending on your situation, you may be contacted periodically to provide updates about your health and treatment outcomes, helping researchers track how genetic mutations affect cancer in real people over time.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States